The contribution of peroxynitrite generation in HIV replication in human primary macrophages
2007

How Peroxynitrite Affects HIV Replication in Macrophages

publication 10 minutes Evidence: moderate

Author Information

Author(s): Stefano Aquaro, Carolina Muscoli, Alessandro Ranazzi, Michela Pollicita, Teresa Granato, Laura Masuelli, Andrea Modesti, Carlo-Federico Perno, Vincenzo Mollace

Primary Institution: Department of Experimental Medicine and Biochemical Sciences, University of Tor Vergata, Rome, Italy

Hypothesis

Superoxide and peroxynitrite may represent important mediators of macrophage-HIV replication.

Conclusion

The study suggests that MnTBAP can significantly reduce HIV-1 replication in macrophages by counteracting oxidative stress.

Supporting Evidence

  • MnTBAP treatment showed a reduction of HIV-1 replication in both acutely and chronically infected macrophages.
  • 99% and 90% inhibition of p24 released in supernatants was observed in acutely and chronically infected macrophages, respectively.
  • MnTBAP inhibited the elevated levels of malondialdehyde during HIV-1 replication.
  • Electron microscopy showed a strong reduction of HIV-1 particles in infected macrophages treated with MnTBAP.

Takeaway

This study shows that a special compound can help stop the virus that causes AIDS from making copies of itself in certain immune cells.

Methodology

The study used MnTBAP to treat acutely and chronically infected macrophages and measured HIV-1 replication through p24 ELISA and other assays.

Limitations

The study did not achieve complete inhibition of HIV replication, especially in chronically infected macrophages.

Participant Demographics

Human primary macrophages from healthy donors were used in the study.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1742-4690-4-76

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication